The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

Kristina Vermeersch,1 Maria Gabrovska,2 Griet Deslypere,3 Ingel K Demedts,4 Hans Slabbynck,5 Joseph Aumann,3 Vincent Ninane,2 GeertM Verleden,1 Thierry Troosters,1,6 Kris Bogaerts,7,8 Guy G Brusselle,9 Wim Janssens1 On behalf of the BACE Trial Investigators 1KU Leuven, Laboratory of Respiratory Diseases, Department of Clinical and Experimental Medicine, Faculty of Medicine, Leuven, Belgium; 2Department of Pneumology, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium; 3Department of Pneumology, Jessa Ziekenhuis, Hasselt, Belgium; 4Department of Respiratory Medicine, AZ Delta Roes... Mehr ...

Verfasser: Vermeersch K
Gabrovska M
Deslypere G
Demedts IK
Slabbynck H
Aumann J
Ninane V
Verleden GM
Troosters T
Bogaerts K
Brusselle GG
Janssens W
Dokumenttyp: Artikel
Erscheinungsdatum: 2016
Reihe/Periodikum: International Journal of COPD, Vol 2016, Iss Issue 1, Pp 687-696 (2016)
Verlag/Hrsg.: Dove Medical Press
Schlagwörter: COPD / Acute exacerbation / Macrolide antibiotics / Azithromycin / Physical activity / Diseases of the respiratory system / RC705-779
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26521860
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doaj.org/article/76ff9a7ed6b9436f9a80161b3552ab1f